OOIR: Observatory of International Research

Papers

(The median citation count of BMJ Open Respiratory Research is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)

Article	Citations
Methamphetamine-associated pulmonary arterial hypertension: data from the national biological sample and data repository for pulmonary arterial hypertension (PAH Biobank)	64
CT airway remodelling and chronic cough	56
Comparing the impact of targeting limited driving pressure to low tidal volume ventilation on mortality in mechanically ventilated adults with COVID-19 ARDS: an exploratory target trial emulation	52
Cannabis use and risks of respiratory and all-cause morbidity and mortality: a population-based, data-linkage, cohort study	42
Signs and symptoms of acute pulmonary embolism and their predictive value for all-cause hospital death in respect of severity of the disease, age, sex and body mass index: retrospective analysis of th	39
Examining the possible causal relationship between lung function, COPD and Alzheimer’s disease: a Mendelian randomisation study	37
Herpes zoster burden in patients with asthma: real-world incidence, healthcare resource utilisation and cost	32
Asthma control with ICS-formoterol reliever versus maintenance ICS and SABA reliever therapy: a post hoc analysis of two randomised controlled trials	31
Coronary artery calcium score may be a novel predictor of COVID-19 prognosis: a retrospective study	30
Exploring the impact of elexacaftor-tezacaftor-ivacaftor treatment on opinions regarding airway clearance techniques and nebulisers: TEMPO a qualitative study in children with cystic fibrosis, their f	30
Cross-sectional study evaluating the impact of SARS-CoV-2 variants on Long COVID outcomes in UK hospital survivors	30
Extracorporeal CO₂removal in acute exacerbation of COPD unresponsive to non-invasive ventilation	29
Bagasse dust exposure and chronic respiratory symptoms among workers in the Metehara and Wonji sugar factories in Ethiopia: a longitudinal study design	28
Smoking and socioeconomic factors linked to acute exacerbations of COPD: analysis from an Asthma + Lung UK survey	28
Chronic respiratory disease observatory for Africa (CHEST-Africa): study protocol for the prevalence, determinants and economic impacts of asthma and COPD in Africa	28
Reference equations for DLNO and DLCO in Mexican Hispanics: influence of altitude and race	26
Exploration of preferences among people with COPD to inform resource allocation: a discrete choice experiment study	26
Correction: Association between influenza vaccination and hospitalisation or all-cause mortality in people with COVID-19: a retrospective cohort study	26
Re-exacerbation within 30 days of discharge is associated with poor prognosis in the following year among patients hospitalised with exacerbation of chronic obstructive pulmonary disease: a clinical c	25
Time-course transcriptome analysis of a double challenge bleomycin-induced lung fibrosis rat model uncovers ECM homoeostasis-related translationally relevant genes	25
Malignant pleural mesothelioma patients’ experience by gender: findings from a cross-sectional UK-national questionnaire	25
Physical activity, sedentary behaviour, and childhood asthma: a European collaborative analysis	25
Lung transplantation for interstitial lung disease: evolution over three decades	24
Integrating patients with chronic respiratory disease and heart failure into a combined breathlessness rehabilitation programme: a service redesign and pilot evaluation	23
Changes in central venous to arterial carbon dioxide gap (PCO₂gap) in response to acute changes in ventilation	23

Developing and validating prediction models for severe exacerbations and readmissions in patients hospitalised for COPD exacerbation (SERCO) in China: a prospective observational study	21
Improved COVID-19 outcomes in a large non-invasive respiratory support cohort despite emergence of the alpha variant	21
Lung cancer in recipients after lung transplant: single-centre experience and literature review	21
Comparison of obstructive sleep apnoea prevalence and severity across WHO pulmonary hypertension groups	21
Impaired lung function and lung cancer risk in 461 183 healthy individuals: a cohort study	20
Lack of racial and ethnic disparities in mortality in minority patients hospitalised with COVID-19 in a mid-Atlantic healthcare system	18
Recommendations following a modified UK-Delphi consensus study on best practice for referral and management of severe asthma	18
Performance monitoring of EBUS for the staging and diagnosis of lung cancer: auditing the Greater Manchester EBUS service against new national standards	17
Canonical correlation analysis of factors that influence quality of life among patients with chronic obstructive pulmonary disease based on QLICD-COPD (V2.0)	17
Application of liquid biopsy-based targeted capture sequencing analysis to improve the precision treatment of non-small cell lung cancer by tyrosine kinase inhibitors	17
Evaluation of the Norwegian version of the Dyspnoea-12 questionnaire in patients with COPD	17
Characteristics and outcomes of patients enrolled in the Connect 360 benralizumab patient support programme in the UK: a retrospective cohort study	16
REMOTE-ILD study: Description of the protocol for a multicentre, 12-month randomised controlled trial to assess the clinical and cost-effectiveness of remote monitoring of spirometry and pulse oximetr	15
Phenotypic characteristics of asthma and morbidity are associated with distinct longitudinal changes in L-arginine metabolism	15
Predicting parameters of airway dynamics generated from inspiratory and expiratory plethysmographic airway loops, differentiating subtypes of chronic obstructive diseases	15
Determinants of multidrug-resistant tuberculosis among adults undergoing treatment for tuberculosis in Tigray Region, Ethiopia: a case–control study	15
Registry-based study in people with cystic fibrosis and anR117Hvariant treated with ivacaftor	14
Objective measurement of lung volume recruitment therapy: laboratory and clinical validation	14
Renin–angiotensin–system inhibitors and the risk of exacerbations in chronic obstructive pulmonary disease: a nationwide registry study	14
Risk factors for pulmonary tuberculosis recurrence, relapse and reinfection: a systematic review and meta-analysis	14
Specialist pneumonia intervention nurse service improves pneumonia care and outcome	14
Systematic review of physiological and psychological outcomes of surgery for pectus excavatum supporting commissioning of service in the UK	13
Correlation of lung function with ultra-low-dose CT-detected lung parenchymal abnormalities: a cohort study of 1344 asbestos exposed individuals	13
Surveillance towards preventing paediatric incidence of respiratory syncytial virus attributable respiratory tract infection in primary and secondary/tertiary healthcare settings in Merseyside, Cheshi	13
Comparison of the efficacy of novel two covering methods for spontaneous pneumothorax: a multi-institutional study	12
Early experiences of the Your COVID Recovery^®digital programme for individuals with long COVID	12
Depression, anxiety and psychological distress in patients with pulmonary hypertension: a mixed-methods study	12
Patient pathways for four major chronic respiratory diseases in England between 2008 and 2021	12
Genomic testing for children with interstitial and diffuse lung disease (chILD): parent satisfaction, understanding and health-related quality of life	12
Randomised trial of first-line bronchial artery embolisation for non-severe haemoptysis of mild abundance	12
Real-world retrospective observational study exploring the effectiveness and safety of antifibrotics in idiopathic pulmonary fibrosis	12
Performance of popular pulse oximeters compared with simultaneous arterial oxygen saturation or clinical-grade pulse oximetry: a cross-sectional validation study in intensive care patients	11
Impact of the COVID-19 pandemic on non-COVID-19 community-acquired pneumonia: a retrospective cohort study	11
6-month regimen of isoniazid prevention therapy for tuberculosis among people living with human immunodeficiency virus in minority areas of China: a 3-year prospective cohort study	11
Patient and public partnership at BMJ Open Respiratory Research	11
Sex differences in asthma control, lung function and exacerbations: the ATLANTIS study	11
‘It’s not one size fits all’: a qualitative study of patients’ and healthcare professionals’ views of self-management for bronchiectasis	11
New method to measure interbreath intervals in infants for the assessment of apnoea and respiration	11
Association between birth weight and chronic obstructive pulmonary disease in the UK Biobank: a prospective cohort study	11
Patients with idiopathic pulmonary fibrosis have poor clinical outcomes with COVID-19 disease: a propensity matched multicentre research network analysis	10
Bronchial rheoplasty for chronic bronchitis: 2-year results from a US feasibility study with RheOx	10
Healthcare experience of adults with COPD during the COVID-19 pandemic: a rapid review of international literature	10
Long-term outcomes following severe COVID-19 infection: a propensity matched cohort study	10
Differences in risk indicators associated with electronic cigarette use and tobacco smoking among adolescents and young people in Nigeria	10
Relationship ofPneumocystisantibody responses to paediatric asthma severity	9
COVID-19 is associated with distinct myopathic features in the diaphragm of critically ill patients	9
Lower geriatric nutritional risk index is associated with a higher risk of all-cause mortality in patients with chronic obstructive pulmonary disease: a cohort study from the National Health and Nutri	9
Physiological changes related to 10 weeks of singing for lung health in patients with COPD	9
Physiological demands of singing for lung health compared with treadmill walking	9
Ultrasonographic assessment of diaphragmatic contraction and relaxation properties: correlations of diaphragmatic displacement with oesophageal and transdiaphragmatic pressure	9

Association of anti-Ro52 autoantibody with interstitial lung disease in autoimmune diseases: a systematic review and meta-analysis	9
Sex-specific alterations in pulmonary metabolic, xenobiotic and lipid signalling pathways after e-cigarette aerosol exposure during adolescence in mice	9
Effect of a home-based inspiratory muscle training programme on functional capacity in postdischarged patients with long COVID: the InsCOVID trial	9
Correlation of respiratory oscillometry with CT image analysis in a prospective cohort of idiopathic pulmonary fibrosis	9
Prevalence, Medicaid use and mortality risk of low FEV₁in adults aged 20–35 years old in the USA: evidence from a population-based retrospective cohort study	8
Validity and reliability of outcome measures to assess dysfunctional breathing: a systematic review	8
Prevalence of swallow, communication, voice and cognitive compromise following hospitalisation for COVID-19: the PHOSP-COVID analysis	8
Clinical features of COVID-19 patients with rebound phenomenon after corticosteroid therapy	8
Nocturnal gastro-oesophageal reflux and respiratory symptoms are increased in sleep apnoea: comparison with the general population	8
Development and validation of a novel questionnaire to describe and assess sensations and triggers associated with refractory and unexplained chronic cough	8
Association between COVID-19 severity and tobacco smoking status: a retrospective cohort study using propensity score matching weights analysis	8
Association of non-obstructive dyspnoea with all-cause mortality and incident chronic obstructive pulmonary disease: a systematic literature review and meta-analysis	8
Systemic inflammation induced by exacerbation of COPD or pneumonia in patients with COPD induces cardiac troponin elevation	8
Use of oral moist tobacco (snus) in puberty and its association with asthma in the population-based RHINESSA study	8
Suboptimal peak inspiratory flow rate: a noticeable risk factor for inhaler concordance in patients with chronic airway diseases	8
National retrospective registry survey on the epidemiology of sarcoidosis in Finland 2002−2022	8
Risk of exacerbation and mortality in asthma: a 10-year retrospective financial database analysis of the Hungarian Health Insurance Fund	8
TELO-SCOPE study: a randomised, double-blind, placebo-controlled, phase 2 trial of danazol for short telomere related pulmonary fibrosis	8
Impacts of regular physical activity on hospitalisation in chronic obstructive pulmonary disease: a nationwide population-based study	8
Differences in uni-dimensional breathlessness measures and thresholds for clinical response in a randomised controlled trial in people with chronic breathlessness: an exploratory study	7
Pulmonary sequelae in 2-year-old children after hospitalisation for respiratory syncytial virus lower respiratory tract infection during infancy: an observational study	7
A Step towards understanding coronary artery disease: a complication in idiopathic pulmonary fibrosis	7
Vitamin D status: a U-shaped relationship for SARS-CoV-2 seropositivity in UK healthcare workers	7
Typical within and between person variability in non-invasive ventilator derived variables among clinically stable, long-term users	7
Reductions in inhaler greenhouse gas emissions by addressing care gaps in asthma and chronic obstructive pulmonary disease: an analysis	7
Comparison of clinical characteristics and outcomes of critically ill adults with SARS-CoV-2 infection during Delta and Omicron variant predominance periods: a single-hospital retrospective cohort stu	7
Feasibility of investigating methylphenidate for the treatment of sarcoidosis-associated fatigue (the FaST-MP study): a double-blind, parallel-arm randomised feasibility trial	7
Rationale and design of the SARCoidosis Outcomes in all respiratory Viral Infectious Diseases (SARCOVID) Study	7
Relationship between body composition, exercise capacity and health-related quality of life in idiopathic pulmonary fibrosis	7
Antibody responses and risk factors associated with impaired immunological outcomes following two doses of BNT162b2 COVID-19 vaccination in patients with chronic pulmonary diseases	7
Evaluation of the Post-COVID-19 Functional Status (PCFS) Scale in a cohort of patients recovering from hypoxemic SARS-CoV-2 pneumonia	7
Enhanced airway sensory nerve reactivity in non-eosinophilic asthma	7
Reflexive thematic analysis exploring stakeholder experiences of virtual pulmonary rehabilitation (VIPAR)	7
Digitally recorded and remotely classified lung auscultation compared with conventional stethoscope classifications among children aged 1–59 months enrolled in the Pneumonia Etiology Research for Chil	6
What if… your research is suddenly affiliated with a tobacco manufacturing company?	6
Patient compliance and satisfaction with a new forehead device for positional obstructive sleep apnoea treatment: a post hoc analysis of a randomised controlled trial	6
Developing an intrasalivary gland botox service for patients receiving long-term non-invasive ventilation at home: a single-centre experience	6
Lung volume measurement using chest CT in COVID-19 patients: a cohort study in Japan	6
Prognostic significance of serum cytokines during acute exacerbation of idiopathic interstitial pneumonias treated with thrombomodulin	6
Rapidly and slowly progressive neuromuscular disease: differences in pulmonary function, respiratory tract infections and response to lung volume recruitment therapy (LVR)	6
Feasibility of dynamic chest radiography to calculate lung volumes in adult people with cystic fibrosis: a pilot study	6
Serum KL-6 levels predict clinical outcomes and are associated withMUC1polymorphism in Japanese patients with COVID-19	6
Secondary erythrocytosis following drugs used in rifampicin/multidrug-resistant tuberculosis: a retrospective cohort study	6
Trending peripheral venous PCO₂in patients with respiratory failure using mathematically arterialised venous blood gas samples	6
Comparative effectiveness of sotrovimab versus no treatment in non-hospitalised high-risk COVID-19 patients in north west London: a retrospective cohort study	6
Circulating testosterone levels and health outcomes in chronic obstructive pulmonary disease: results from ECLIPSE and ERICA	6
Hospital-level variation in practices and outcomes for patients with severe acute exacerbations of idiopathic pulmonary fibrosis: a retrospective multicentre cohort study	6
Transitioning from hospital to home with non-invasive ventilation: who benefits? Results of a cohort study	6
Whole-course management of chronic obstructive pulmonary disease in primary healthcare: an internet of things-enabled prospective cohort study in China	6
Association of sleep apnoea risk and aortic enlargement in Marfan syndrome	6
Home high-flow therapy during recovery from severe chronic obstructive pulmonary disease (COPD) exacerbation: a mixed-methods feasibility randomised control trial	5
Estimating population-based incidence of community-acquired pneumonia and acute otitis media in children and adults in Ontario and British Columbia using health administrative data, 2005–2018: a Canad	5
Understanding clinical decision-making in mesothelioma care: a mixed methods study	5
Lung ultrasound volume sweep imaging for respiratory illness: a new horizon in expanding imaging access	5
Symptomatic, biochemical and radiographic recovery in patients with COVID-19	5
Needs assessment for introducing pulmonary rehabilitation for chronic obstructive pulmonary disease management in a rural Indian setting: a qualitative study	5
Vitamin D status and chronic obstructive pulmonary disease risk: a prospective UK Biobank study	5
Definitions of pulmonary exacerbation in people with cystic fibrosis: a scoping review	5
Association between air pollutant exposure, body water distribution and sleep disorder indices in individuals with low-arousal-threshold obstructive sleep apnoea	5
Burden of COPD in China and the global from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019	5
Characteristics, treatment patterns and burden of illness in US patients with asthma newly initiating multiple-inhaler triple therapy	5
Real-world treatment trajectories of adults with newly diagnosed asthma or COPD	5
Association of high-sensitivity CRP and FEV1%pred: a study on non-pulmonary disease in a population in Beijing, China	5
Contribution of collagen XIII to lung function and development of pulmonary fibrosis	5
Stability in eosinophil categorisation during subsequent severe exacerbations of COPD	5
Long-term cohort study of patients presenting with hypercapnic respiratory failure	5
Efficacy of convalescent plasma for treatment of COVID-19 in Uganda	5
Characterisation of patients with chronic obstructive pulmonary disease initiating single-device inhaled corticosteroids/long-acting β₂-agonist dual therapy in a primary care setting in Eng	5
Phenotyping the Responses to Systemic Corticosteroids in the Management of Asthma Attacks (PRISMA): protocol for an observational and translational pilot study	5
Undiagnosed and ‘overdiagnosed’ COPD using postbronchodilator spirometry in primary healthcare settings: a systematic review and meta-analysis	5
Mycophenolate and azathioprine efficacy in interstitial lung disease: a systematic review and meta-analysis	5
Elucidating the risk of cardiopulmonary consequences of an exacerbation of COPD: results of the EXACOS-CV study in Germany	5
Exogenous pulmonary surfactant in COVID-19 ARDS. The similarities to neonatal RDS suggest a new scenario for an ‘old’ strategy	5
Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response	5
Temperature synchronisation of circadian rhythms in primary human airway epithelial cells from children	5
Measurement of breathing in patients with post-COVID-19 using structured light plethysmography (SLP)	5
Efficacy of different respiratory supports to prevent hypoxia during flexible bronchoscopy in patients of COPD: a triple-arm, randomised controlled trial	5
Is it time to include oxygen needs as an endpoint in clinical trials in patients with fibrosing interstitial lung disease? If so, how?	5
Influencing factors of sedentary behaviour in people with chronic obstructive pulmonary disease: a systematic review	5
Fast decliner phenotype of chronic obstructive pulmonary disease (COPD): applying machine learning for predicting lung function loss	5

Aetiology of acute respiratory infection in preschool children requiring hospitalisation in Europe—results from the PED-MERMAIDS multicentre case–control study	5
Clinical characteristics, diagnosis, outcomes and lung microbiome analysis of invasive pulmonary aspergillosis in the community-acquired pneumonia patients	5
Clinical utility of elective paediatric flexible bronchoscopy and impact on the quality of life: protocol for a single-centre, single-blind, randomised controlled trial	5
Therapeutic effects of fatty acid binding protein 1 in mice with pulmonary fibrosis by regulating alveolar epithelial regeneration	5
Inhaled corticosteroid dose is associated withPseudomonas aeruginosainfection in severe COPD	4
Performance evaluation of human cough annotators: optimal metrics and sex differences	4
Defining hypoxaemia from pulse oximeter measurements of oxygen saturation in well children at low altitude in Bangladesh: an observational study	4
Compensatory function change by segment-counting method in predicted postoperative pulmonary function at 1 year after surgery: systematic review and meta-analysis	4
Patient perspectives on knowledge gaps in hypersensitivity pneumonitis	4
Differential clinicopathological features, treatments and outcomes in patients with Exon 19 deletion and Exon 21 L858R EGFR mutation-positive adenocarcinoma non-small-cell lung cancer	4
¹²⁹Xe MRI ventilation defects in ever-hospitalised and never-hospitalised people with post-acute COVID-19 syndrome	4
Pim1 inactivating induces RUNX3 upregulation that improves/alleviates airway inflammation and mucus hypersecretion in vitro and in vivo	4
Chest radiograph-based artificial intelligence predictive model for mortality in community-acquired pneumonia	4
Rate of severe exacerbations, healthcare resource utilisation and clinical outcomes in patients with COPD in low-income and middle-income countries: results from the EXACOS International Study	4
British Thoracic Society survey of the career intentions of respiratory medicine specialty trainees in the UK	4
Frailty assessment for COVID-19 follow-up: a prospective cohort study	4
Efficacy and safety of an inhaled pan-Janus kinase inhibitor, nezulcitinib, in hospitalised patients with COVID-19: results from a phase 2 clinical trial	4
Omalizumab for Chinese patients with moderate-to-severe allergic asthma in real-world clinical setting: a prospective, observational study	4
Pragmatic randomised controlled trials in COPD and asthma: how to guide clinical practice	4
Adherence to application technique of inhaled corticosteroid in patients with asthma and COVID-19 improves outcomes	4
Thyroid-stimulating hormone and mortality in pulmonary arterial hypertension	4
Exploring the appropriateness of prescribing practice of inhaled pharmacotherapy among Aboriginal Australians in the Top End Northern Territory of Australia: a retrospective cohort study	4
Ventilator performances for non-invasive ventilation: a bench study	4
Sleep apnoea and hypoventilation in patients with five major types of muscular dystrophy	4
Impact of early caffeine administration on respiratory outcomes in very preterm infants initially receiving invasive mechanical ventilation	4
Medication use of Canadians with chronic obstructive pulmonary disease: a cohort study	4
Exploration of therapists’ views of practice within critical care	4
Beta-blockers reduce severe exacerbation in patients with mild chronic obstructive pulmonary disease with atrial fibrillation: a population-based cohort study	4
Research priorities for progressive pulmonary fibrosis in the UK	4
Diagnostic delay in IPF impacts progression-free survival, quality of life and hospitalisation rates	4
Association of alpha globin gene copy number with exhaled nitric oxide in a cross-sectional study of healthy Black adults	4
Managing moderate-to-severe paediatric asthma: a scoping review of the efficacy and safety of fluticasone propionate/salmeterol	4
Feasibility of home initiation of an airway clearance device (SIMEOX) by telecare in people with non-cystic fibrosis bronchiectasis: a pilot study	4
Prevalence and risk factors for COPD in subjects with preserved ratio impaired spirometry	4
Correction: Pulmonary vasculopathy in explanted lungs from patients with interstitial lung disease undergoing lung transplantation	4
Hospital-based multidisciplinary lung cancer care in Australia: a survey of the landscape in 2021	4
COPD disease knowledge, self-awareness and reasons for hospital presentations among a predominately Indigenous Australian cohort: a study to explore preventable hospitalisation	4
Validation of the STOP-Bang questionnaire as a screening tool for obstructive sleep apnoea in patients with cardiovascular risk factors: a systematic review and meta-analysis	4
Sequential exploratory mixed-method research of an eHealth intervention on blood pressure, sleep quality and physical activity in obstructive sleep apnoea: rationale and methodology of the Moore4Medic	4
COVID-19 recovery: benefits of multidisciplinary respiratory rehabilitation	4
Impact of COVID-19 on people with asthma: a mixed methods analysis from a UK wide survey	4
Withdrawal of inhaled corticosteroids from patients with COPD with mild or moderate airflow limitation in primary care: a feasibility randomised trial	4
Inspiratory crackles—early and late—revisited: identifying COPD by crackle characteristics	4
Bile acids in the lower airways is associated with airway microbiota changes in chronic obstructive pulmonary disease: an observational study	4
Perinatal and early life factors and asthma control among preschoolers: a population-based retrospective cohort study	4
Reliability and responsiveness of the D12 and validity of its scores as a measure of dyspnoea severity in patients with rheumatoid arthritis-related interstitial lung disease	4
Clinical utility of anti-interleukin 5 monoclonal therapy in asthma using a national, centralised, outcome-based system of drug access	3
Correlation of programmed death-ligand 1 expression in tumour cells between diagnostic small biopsies performed by radial EBUS and surgical specimens of peripheral lung cancer	3
Optimal resection rate for lung cancer in the UK: how high should we go?	3
Clinical characteristics of patients with a risk of pulmonary artery hypertension secondary to ARDS in a high-altitude area	3
Does routine spirometry impact on clinical decisions and patient-related outcome measures of children seen in respiratory clinics: an open-label randomised controlled trial	3
Lung function may recover after coal mine fire smoke exposure: a longitudinal cohort study	3
Impact of dietary nitrate supplementation on exercise capacity and cardiovascular parameters in chronic respiratory disease: a systematic review and meta-analysis	3
Strong and graded associations between level of asthma severity and all-cause hospital care use and costs in the UK	3
Risk factors for asthma-related hospital and intensive care admissions in children, adolescents and adults: a cohort study using primary and secondary care data	3
Lung fluid content during 6MWT in patients with COPD with and without comorbid heart failure	3
Impact on quality of life from multimodality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multimodality treatment in potentially resecta	3
Singing for lung health in COPD: a multicentre randomised controlled trial of online delivery	3
Prospectively evaluating maternal and fetal outcomes in the era of CFTR modulators: the MAYFLOWERS observational clinical trial study design	3
Monocyte and neutrophil levels are potentially linked to progression to IPF for patients with indeterminate UIP CT pattern	3
Association between serum high-density lipoprotein cholesterol and lung function in adults: three cross-sectional studies from US and Korea National Health and Nutrition Examination Survey	3
Feasibility and acceptability of a community pharmacy referral service for suspected lung cancer symptoms	3
Implementation of prognostic machine learning algorithms in paediatric chronic respiratory conditions: a scoping review	3
Large scale clinical trials: lessons from the COVID-19 pandemic	3
Potential for integrating yoga within pulmonary rehabilitation and recommendations of reporting framework	3
Incidence of bleeding in patients on different anticoagulants and antiplatelet therapies undergoing thoracentesis	3
Association between serum uric acid/serum creatinine ratios and lung function in the general American population: National Health and Nutrition Examination Survey (NHANES), 2007–2012	3
Registry-based cohort study of alpha-1 antitrypsin deficiency prevalence, incidence and mortality in Denmark 2000–2018	3
Nasal microRNA signatures for disease severity in infants with respiratory syncytial virus bronchiolitis: a multicentre prospective study	3
Beyond direct costs: individual and societal financial burden of asthma in young adults in a Danish nationwide study	3
Breathlessness dimensions association with physical and mental quality of life: the population based VASCOL study of elderly men	3
Assessment of SARS-CoV-2 infectivity of upper respiratory specimens from COVID-19 patients by virus isolation using VeroE6/TMPRSS2 cells	3
Antifibrotic treatment adherence, efficacy and outcomes for patients with idiopathic pulmonary fibrosis in Spain: a real-world evidence study	3
Neutrophil–lymphocyte ratio in patients with idiopathic pleuroparenchymal fibroelastosis	3
Pulmonary hypertension survival and hospitalisations in people living with HIV: a systematic review and meta-analysis	3
Effect of a postoperative home-based exercise and self-management programme on physical function in people with lung cancer (CAPACITY): protocol for a randomised controlled trial	3
Safety and efficacy of catheter directed thrombolysis (CDT) in elderly with pulmonary embolism (PE)	3
Asthma, rhinitis and eczema symptoms in Quito, Ecuador: a comparative cross-sectional study 16 years after ISAAC	3
SARS-CoV2 in public spaces in West London, UK during COVID-19 pandemic	3
BTS clinical statement for the diagnosis and management of ocular tuberculosis	3
Remote exposure to secondhand tobacco smoke is associated with lower exercise capacity through effects on oxygen pulse, a proxy of cardiac stroke volume	3
Efficacy of one time per day, single-inhaler indacaterol/glycopyrronium/mometasone in patients with inadequately controlled asthma: post hoc analysis of IRIDIUM study in Asian population	3
Association of body mass index with morbidity in patients hospitalised with COVID-19	3
Effect of stellate ganglion block on perioperative myocardial injury following thoracoscopic surgery for lung cancer (SGBMI): protocol for a single-centre, randomised controlled trial	3
In vivo polarisation sensitive optical coherence tomography for fibrosis assessment in interstitial lung disease: a prospective, exploratory, observational study	3
Outcomes of patients with COPD switching from multiple-inhaler to once-daily single-inhaler triple therapy in a real-world primary care setting in England: a retrospective pre-post cohort study	3
Cardiovascular outcomes following hospitalisation for exacerbation of bronchiectasis: a territory-wide study	3
Home-based pulmonary rehabilitation early after hospitalisation in COPD (early HomeBase): protocol for a randomised controlled trial	3
Real-world implementation of the National Early Warning Score-2 in an acute respiratory unit	3
Haemoglobin value and red blood cell transfusions in prolonged weaning from mechanical ventilation: a retrospective observational study	3
Characteristics of new adult users of mepolizumab with asthma in the USA	3
Hyperlipidaemia and mortality among patients hospitalised with pneumonia: retrospective cohort and propensity score matched study	3
Virtual respiratory therapy delivered through a smartphone app: a mixed-methods randomised usability study	3
Fine crackles on chest auscultation in the early diagnosis of idiopathic pulmonary fibrosis: a prospective cohort study	3
Inhaled treprostinil in patients with pulmonary hypertension associated with interstitial lung disease with less severe haemodynamics: a post hoc analysis of the INCREASE study	2